Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina N Bennett

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 18, 2018
Revised guidelines to enhance the rigor and reproducibility of research published in American Physiological Society journalsGina L C Yosten, Josephine C Adams, Christina N Bennett, et al.
Diabetes|January 30, 2007
Wnt10b inhibits obesity in ob/ob and agouti miceWendy S Wright, Kenneth A Longo, Vernon W Dolinsky, et al.
Breast Cancer Research : BCR|July 21, 2012
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancerChristina N Bennett, Christine C Tomlinson, Aleksandra M Michalowski, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 18, 2018
Revised guidelines to enhance the rigor and reproducibility of research published in American Physiological Society journalsGina L C Yosten, Josephine C Adams, Christina N Bennett, et al.
Diabetes|January 30, 2007
Wnt10b inhibits obesity in ob/ob and agouti miceWendy S Wright, Kenneth A Longo, Vernon W Dolinsky, et al.
Breast Cancer Research : BCR|July 21, 2012
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancerChristina N Bennett, Christine C Tomlinson, Aleksandra M Michalowski, et al.
Pageof 2